Pharmacological Inhibition of DNA Methylation Induces Proinvasive and Prometastatic Genes In Vitro and In Vivo
The mechanism of action of DNA methylation inhibitor 5-aza-2′-deoxycytidine (5-aza-CdR), a potential anticancer agent is believed to be activated by the demethylation of tumor suppressor genes. We tested here the hypothesis that demethylating agents also demethylate and activate genes involved in in...
Main Authors: | Bushra Ateeq, Alexander Unterberger, Moshe Szyf, Shafaat A Rabbani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-03-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558608801236 |
Similar Items
-
Corrigendum to “Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo” [Neoplasia 10/3 (2008) 266-278]
by: Bushra Ateeq, et al.
Published: (2022-05-01) -
DNA methylation signatures of Prostate Cancer in peripheral T-cells
by: Ali Mehdi, et al.
Published: (2020-06-01) -
Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition
by: Niaz Mahmood, et al.
Published: (2024-04-01) -
LIF Mediates Proinvasive Activation of Stromal Fibroblasts in Cancer
by: Jean Albrengues, et al.
Published: (2014-06-01) -
DNA methylation signatures of breast cancer in peripheral T-cells
by: Surabhi Parashar, et al.
Published: (2018-05-01)